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ABSTRACT Protein kinase C- (PKC-) plays a central role in cardiac cell signaling, but mechanisms of translocation and
anchoring upon activation are poorly understood. Conventional PKC isoforms rely on a rapid Ca2-mediated recruitment to
cell membranes, but this mechanism cannot be employed by PKC- or other PKC isoforms lacking a Ca2-binding domain.
In this study, we used recombinant green fluorescent protein (GFP) fusion constructs and confocal microscopy to examine
the localization, kinetics, and reversibility of PKC- anchoring in permeabilized rat cardiac myocytes. PKC--GFP bound with
a striated pattern that co-localized with -actinin, a marker of the Z-line of the sarcomere. Binding required activation of PKC
and occurred slowly but reversibly with apparent rate constants of kon  4.6  1.2  10
3 M1 s1 and koff  1.4  0.5 
103 s1 (t1/2  8 min) as determined by fluorescence recovery after photobleaching and by perfusion experiments. A
truncated construct composed of the N-terminal 144-amino-acid variable region of PKC- (V1-GFP), but not an analogous
N-terminal domain of PKC-, mimicked the Z-line decoration and slow binding rate of the full-length enzyme. These findings
suggest that the V1 domain is important in determining PKC- localization and translocation kinetics in cardiac muscle.
Moreover, PKC- translocation is not a diffusion-controlled binding process but instead may be limited by intramolecular
conformational changes within the V1 domain. The koff for V1-GFP was two- to threefold faster than for full-length enzyme,
indicating that other domains in PKC- contribute to anchoring by prolonging the bound state.
INTRODUCTION
Protein kinase C (PKC) is widely recognized as a central
regulatory species in a variety of physiological systems. At
least 11 distinct PKC isoforms have been identified by
molecular and biochemical analysis (Nishizuka, 1992). The
conventional PKC (cPKC) isoforms , I, II, and  are
regulated by phosphatidylserine, diacylglycerol, and Ca2.
More recently, several novel PKC (nPKC) isoforms , , ,
and  have been shown to be Ca2 independent and regu-
lated primarily by phosphatidylserine and diacylglycerol.
PKC typically undergoes redistribution from one intracel-
lular region to another upon stimulation by various intra-
cellular signaling factors, including diacylglycerol, fatty
acids, and in the case of the cPKC isoforms, calcium. This
translocation effect occurs over the course of seconds to
minutes, with each isoform exhibiting a characteristic pat-
tern and time course of redistribution (Disatnik et al., 1994;
Jaken, 1996; Kiley et al., 1995). The mechanism of this
enzyme translocation and anchoring has been most widely
investigated for conventional PKC isoforms, which seem to
translocate and partition rapidly into cell membranes
through a Ca2-binding C2 domain. PKC isoforms thought
to be important in modulating cardiac contractility include
novel isoforms, PKC- and PKC-, which lack this Ca2-
binding C2 domain and are therefore likely to translocate by
a distinct mechanism.
The  isoform of PKC has garnered considerable scrutiny
in cardiac signaling because of its association with ischemic
preconditioning (IP), a phenomenon wherein a temporary
period of reduced blood flow confers protection against a
subsequent prolonged ischemic insult (Murry et al., 1986;
Albert and Ford, 1999; Kawamura et al., 1998; Ping et al.,
1997; Qiu et al., 1998). Of particular interest is the sugges-
tion that a delay in the onset of cardioprotection is due to the
time taken for PKC- translocation and that the memory of
preconditioning is due to PKC dwelling in a translocated
state (discussed in Cohen et al., 2000, and sources therein).
This provides a compelling reason to establish the mecha-
nism and kinetics of PKC- translocation in the heart.
The evidence linking translocation to regulation of con-
tractility or to cardioprotection fosters a great interest in the
mechanism by which PKC exerts its effects, and efforts
have been made to identify important activators, anchoring
proteins, and target substrates. Previous fluorescence immu-
nolabeling studies in the heart showed PKC- binding in a
striated, sarcomeric pattern visible by epifluorescence and
confocal microscopy (Disatnik et al., 1994; Huang et al.,
1997). Binding of PKC- to Golgi structures, cell-cell con-
tacts, perinuclear regions, and intercalated disks has also
been reported in cardiac tissues (Csukai et al., 1997; Wang
and Ashraf 1998). Certain phases of PKC- translocation
occur in the time domain of 5–20 min (Huang et al., 1997),
but the steps in the signaling cascade responsible for this
slow rate have not been identified.
To better understand the Ca2-independent translocation
and anchoring of the novel PKC- isoform, we have exam-
ined the binding and dissociation properties of purified
green fluorescent protein (GFP) fusion constructs applied to
isolated permeabilized rat cardiac myocytes. The use of
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permeabilized cells permitted the concentration of fluores-
cent probes to be known and readily varied over a wide
range. A major advantage of this approach over immuno-
localization techniques is that binding can be monitored
over time with confocal microscopy, allowing determina-
tion of dynamic parameters such as on/off rates and equi-
librium binding constants. This study provides the first
estimates of these dynamic parameters for PKC- binding
near the Z-line of cardiac cells.
MATERIALS AND METHODS
All reagents were obtained from Sigma Chemical Co. (St. Louis, MO)
unless noted otherwise. Phorbol 12-myristate 13-acetate (PMA) and 4--
phorbol-didecanoate (4--PDD) were obtained from Calbiochem (La Jolla,
CA) and prepared as 1 mM stock solutions in dimethylsulfoxide. Colla-
genase was obtained from Worthington Enzymes (Freehold, NJ).
Cardiac myocyte preparation
Ventricular cardiac myocytes were isolated from adult male Sprague-
Dawley rats by enzymatic digestion with collagenase and hyaluronidase, as
previously described (Huang et al., 1996). Myocytes were then permeabil-
ized with 100 	g/ml saponin for 5 min at 20°C in relaxing solution of the
following composition: 100 mM KCl, 1 mMMgCl2, 2 mM EGTA, 4.5 mM
ATP, 10 mM imidazole, 1 mM dithiothreitol, pH 7.0. Cells were washed
and resuspended in relaxing solution containing 5% bovine serum albumin
to block nonspecific binding of applied probes.
Molecular biology and protein expression
A PKC--GFP fusion protein was expressed in SF-9 or SF-21 insect cells
using a commercial baculovirus expression system Fastbac1 (GibcoBRL-
Life Technologies, Gaithersburg, MD). The enhanced-GFP gene was ex-
cised from pEGFP-C1 (Clontech, Palo Alto, CA) and inserted into a
previously engineered plasmid 5 to the gene encoding PKC-. This plas-
mid, derived from the Life Technologies pFASTBAC vector, undergoes
recombination in DH10Bac cells, making a bacmid suitable for insect cell
transfection. PKC was purified from insect cell lysates using a Vision
purification system (PE Biosystems, Foster City, CA) equipped with rapid
perfusion anion exchange columns. The fusion protein thus produced was
enzymatically active and regulated by the PKC activator phorbol 12-
myristate 13-acetate (PMA) as determined by a commercially available
assay, MESACUP protein kinase assay kit (Pan Vera, Madison, WI). The
specific activity of PKC--GFP was determined by [32P]phosphate incor-
poration into myelin basic protein using a previously described enzymatic
assay (Huang et al., 1996). PMA-dependant activity was found to be 28
U/mg protein (where 1 U  1 nmol of phosphate transferred per minute),
with a PMA-independent basal activity of 4 U/mg protein. This is similar
to the specific activity of commercially available PKC- (Panvera, Madi-
son, WI), which had a PMA-dependent activity of 60 U/mg protein, under
the same assay conditions.
The V1 regions of PKC- and PKC- were amplified from a mouse
brain cDNA library (Stratagene, La Jolla, CA) by the polymerase chain
reaction (PCR) and inserted into pEGFP (Clontech). The V1-GFP con-
struct contained a histidine-tag sequence and was purified from DH5-
Escherichia coli cell lysate using a column of Ni-NTA Superflow beads
(Qiagen, Valencia, CA). The V1-GFP fusion gene was subcloned into
pGEX-2T (Amersham Pharmacia, Piscataway, NJ) and expressed as a
glutathione-S-transferase (GST)-tagged protein. After purification with
glutathione Sepharose 4B beads (Amersham), the GST tag was removed by
thrombin cleavage.
Confocal microscopy
Imaging was performed with a Bio-Rad MRC 1024 laser scanning confocal
microscope equipped with a mixed gas (Ar/Kr) laser operated by 24-bit
LaserSharp software. Image acquisition in the green channel utilized ex-
citation at 488 nm with emission detected at 522  17 nm. Acquisition in
the red channel utilized excitation at 568 nm with emission detected at
605  16 nm. Immunolabeling of -actinin was performed with a com-
mercial monoclonal antibody EA-53 (Sigma Immunochemical, St. Louis,
MO) diluted 1:100, and anti-mouse IgG secondary antibody labeled with
tetramethyl-rhodamine isothiocyanate (TRITC) (Boehringer Mannheim,
Indianapolis, IN) or Alexa 568 (Molecular Probes, Eugene, OR) diluted
1:50. GFP fusion constructs were applied at 200–600 nM for localization
studies. PKC--GFP was activated by preincubation in relaxing solution
containing stoichiometric concentrations of PMA, except where indicated.
The V1-GFP construct does not contain the C1 domain implicated in
phorbol ester binding (Ono et al., 1989) and was not treated with exoge-
nous activators in these experiments.
Heat denaturation control experiments were performed by dilution of
PKC--GFP in relaxing solution followed by incubation at 70°C for 10
min. This treatment did not significantly affect the fluorescence of GFP
constructs consistent with the fact that GFP itself possesses considerable
thermal stability (Ward et al., 1982).
Photobleaching of saponin-permeabilized myocytes decorated with
GFP constructs was performed by increasing laser power from 30% to
100% and enhancing scan zoom by a factor of 10. This increased the
intensity of laser illumination by 300-fold, destroying GFP chroma-
phores in a region measuring 16 	m  16 	m. Fluorescence recovery was
then observed by acquiring single images at 1-min intervals for 20 min.
Image analysis was performed with Scion Image (Scion Corp., Frederick
MD), Confocal Assistant (Bio-Rad, Hercules, CA), and Metamorph (Uni-
versal Imaging Corp., West Chester, PA). Fluorescence intensity plots
were generated from confocal images using these programs to draw
straight scan paths parallel to the long axis of the cell. The paths thus
intersected the repetitive striations, yielding a multiply peaked trace that
was analyzed manually and automatically with a custom peak height
detection program developed by Dr. K. S. Campbell, University of Wis-
consin Department of Physiology. This program identified peaks in the
fluorescence intensity/position plot based on local maxima and minima that
satisfy designated threshold criteria. The program determined and dis-
played the mean peak height (SD) and mean fluorescence intensity
(SD).
In PKC--GFP washout experiments, isolated, permeabilized myocytes
were settled onto the glass coverslip floor of a custom perfusion chamber
and decorated with 50–100 nM PKC--GFP. After probe equilibration, the
cells were perfused with fresh buffer using a peristaltic pump (Scientific
Industries, Bohemia, NY) and monitored by confocal microscopy, acquir-
ing one frame every 30 s for 1–2 h. The amount of PKC--GFP bound was
evaluated at each time point as the average fluorescence of a rectangular
section. In some cases, individual cells were held in place on the surface of
the coverslip using a stainless steel probe mounted on a micro-manipulator
apparatus (Narishige, Tokyo, Japan) to prevent cells from shifting position
during rapid solution changes.
Kinetic measurements
Time courses of binding and unbinding were determined quantitatively by
monitoring the fluorescence intensity within myocytes or within the 16-	m
 16-	m bleached region over the entire acquisition period. Fluorescence
intensity time courses were fit to single exponentials to obtain first-order
rate constants that were consistent with the independent measure of rates
by visual inspection. Half-time values estimated for striation development
or photobleaching recovery were consistent between three observers
blinded to sample identity. Half-times were converted to observed rate
constants by k  (ln2)/t1/2.
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RESULTS
Localization of activated PKC-GFP
Recombinant PKC--GFP was incubated with saponin-
skinned myocytes to determine the subcellular location of
PKC- binding in heart myocytes. In the absence of activa-
tors, PKC--GFP stained only at low levels and diffusely
throughout the cells (Fig. 1 A). Activation with 100 nM
PMA increased binding of PKC--GFP to longitudinal
structures as well as the perinuclear region (Fig. 1 B).
Inclusion of 100 nM Zn2 plus 100 nM PMA provided the
most reproducible staining pattern characterized by promi-
FIGURE 1 Confocal images of isolated permeabilized myocytes after incubation with 100 nM PKC--GFP. (A) PKC--GFP in relaxing solution with
no activators; (B) PKC--GFP plus 100 nM PMA; (C) PKC--GFP plus 100 nM PMA plus 100 nM ZnCl2; (D) As in C, a higher magnification image
averaged from three sequential acquisitions; (E) PKC--GFP plus 100 nM ZnCl2 plus 100 nM 4--PDD, a biologically inactive phorbol ester; (F) 400 nM
EGFP not fused to PKC. Scale bars, 10 	m.
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nent decoration of intercalated disks and a pronounced
cross-striated staining pattern (Fig. 1, C and D). Nanomolar
levels of Zn2 are presumably required for proper folding
and function of the C1 domains containing zinc fingers.
Only active PKC--GFP bound, as no staining was observed
in the presence of the inactive phorbol ester, 4--PDD (Fig.
1 E), and normal binding was prevented by heat denatur-
ation of PKC--GFP (70°C, 10 min; not shown). Moreover,
EGFP itself did not bind to myocytes significantly, as no
decoration of cross-striations or of intercalated disks was
observed with unconjugated EGFP (Fig. 1 F). In these
images with EGFP alone, cells appear darker than the bath
in part because the saponin permeabilization technique is
selective for the plasma membrane (Endo and Iino 1980),
and therefore intracellular membrane compartments such as
mitochondria and the sarcoplasmic reticulum are inaccessi-
ble to freely diffusible EGFP.
The intensity of bound PKC--GFP fluorescence varied
with protein concentration over the range 20–160 nM. Due
to limits on attaining higher concentrations of PKC--GFP,
we were unable to demonstrate saturation of binding to
intercalated disks or to cross-striated structures. The satu-
rability and specificity of binding were confirmed by pre-
incubation of myocytes with activated unlabeled PKC- (3
	M protein plus 200 nM PMA), which reduced the propor-
tion of fluorescent striated cells from 40% to 	10% (data
not shown). Overall the data are consistent with the notion
that upon activation PKC- preferentially anchors to spe-
cific cross-striated structures and intercalated disks in car-
diac myocytes. This staining pattern including the exclusion
of PKC--GFP from the nucleus is similar to what was
observed previously by immunofluorescence (Huang et al.,
1997).
To further establish the localization of activated PKC--
GFP we compared the staining pattern with the localization
of -actinin, a structural protein recognized to be a marker
of the Z-line region of the sarcomere. Fig. 2 (left panel)
shows the pattern obtained with a commercial polyclonal
antibody to -actinin detected by an Alexa 568-labeled
secondary antibody. The middle panel of Fig. 2 illustrates a
typical PKC--GFP image, and the right panel merges the
GFP and Alexa 568 channels to highlight regions of over-
lap. Yellow regions in the merged image demonstrate clear
co-localization of activated PKC--GFP with -actinin.
Decoration of the Z-line was analyzed in the remainder of
this study because it was more amenable to quantification
and was quite reproducible from cell to cell.
FRAP of PKC--GFP
Fluorescence recovery after photobleaching (FRAP) mea-
surements were employed to measure the kinetics of PKC-
binding and unbinding. FRAP has the advantage that cells
are premixed with PKC--GFP and allowed to fully equil-
ibrate before the bleaching perturbation. Fig. 3 A illustrates
the recovery of striations in a square bleached region of
permeabilized myocytes decorated with PKC--GFP. Esti-
mates for photobleaching recovery rates were obtained by
two separate approaches (details in Materials and Methods)
that gave results in close agreement.
The rate of photobleaching recovery was found to depend
on the concentration of PKC--GFP applied to the cells. Fig.
3 B shows that kFRAP increases with increasing concentra-
tion of PKC--GFP. The recovery of striations from photo-
bleaching implies PKC--GFP binds reversibly and thus
equilibrates dynamically between bound and free states as






In the photobleaching experiments, the rate of recovery of a
bleached region is determined by both the binding and
unbinding rate constants, because bound, bleached mole-
FIGURE 2 Co-localization of activated PKC--GFP with the Z-line of cardiac myocytes. (Left panel) A confocal image of isolated permeabilized
myocytes decorated with a monoclonal anti--actinin antibody and Alexa 568-labeled secondary antibodies detected in the red channel; (Middle panel) The
same cardiac myocyte decorated with activated PKC--GFP detected in the green channel. (Right panel) Regions of overlap between the two fluorescence
channels containing -actinin and PKC--GFP, respectively, are illustrated in yellow.
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cules of PKC--GFP must vacate binding sites for un-
bleached species to bind from the available pool in free
solution. Consequently, the recovery rate constant, kFRAP, is
an integrated measure of kon and koff as follows: kFRAP kon
[PKC--GFP]  koff. In this relationship, only kon is in a
concentration-dependent term, and thus one observes kFRAP
over a range of concentrations to dissect kon from koff. The
linear regression in Fig. 3 B gives a slope, kon  4.6 
1.2  103 M1 s1 and a y-intercept, koff  0.75  0.1 
103 s1. The affinity can be determined from these values
according to their relationship to the dissociation constant as
follows: Kd  koff/kon. By this analysis, the apparent Kd for
PKC--GFP was found to be 160 nM.
Probe diffusion
Importantly, the low kon values reported above argue against
a diffusion-limited binding process. It is interesting to note
that areas of the photobleaching square that overhang the
edge of the cell do not cause any detectable bleaching of
fluorescence in the extracellular bath solution (seen best in
left image of Fig. 3 A), because the bleached area in free
solution recovers immediately. Thus, diffusion in free so-
lution is much faster than the formation of the striation
staining pattern. This is consistent with the observation that
the 16-	m  16-	m bleached region does not change size
or shape during the recovery process. If recovery of the
striation pattern were determined by the diffusion rate, then
the pattern would be expected to close in from the perimeter
of the bleached region. This was not observed, but rather
recovery of striations was uniform across the bleached
square. This is demonstrated graphically in Figs. 3 B and 8
B. Line-scan fluorescence quantification traces across the
bleached area maintain a characteristic square-stepped
shape throughout the recovery process, indicating uniform
recovery of fluorescence. Additional analyses show that the
FIGURE 3 Photobleaching recovery of myocytes decorated with PKC--GFP. (A) A permeabilized myocyte equilibrated with 150 nM activated
PKC--GFP was photobleached in a 16  16 	m square. Recovery of the striation pattern is shown here in four panels at 0, 5, 10, and 15 min after
photobleaching. (B) A line-scan quantification of fluorescence intensity versus position across the bleached region shows a uniform recovery of fluorescence
over time. (C) Dependence of the rate of photobleaching recovery, kFRAP, upon the concentration of applied probe. A linear regression fit gave a slope,
kon  4.6  1.2  103 M1s1, and y-intercept, koff  0.75  0.10  103 s1. Overlapping data are offset. (Inset) Mean kFRAP values  SEM at low
(31 nM) and high (110 nM) concentrations of PKC--GFP. Data are represented as mean  SEM; asterisk indicates statistical significance with p 	 0.05.
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corners of the bleached area recover with the same time
dependence as the center (not shown).
Additional control experiments were performed to ad-
dress whether the saponin-permeabilized plasma membrane
presented a barrier to diffusion, using unconjugated EGFP
as a freely diffusible probe. As shown in Fig. 1 F, the
fluorescence signal of EGFP in permeabilized cells is low.
To distinguish EGFP from background autofluorescence, a
region of the cell was pre-bleached before application of
probe. Fluorescence of this region was monitored and com-
pared with an extracellular reference as EGFP was perfused
into the bath. The fluorescence increase in the intracellular
region followed the rise in extracellular fluorescence with-
out a detectable delay, indicating that the permeabilized
membrane did not measurably impede probe access to in-
tracellular regions on the time scale of the frame acquisition
rate (one every 15 s).
These empirical observations are in harmony with theo-
retical predictions of diffusion parameters and photobleach-
ing recovery in this experimental context. Green fluorescent
protein has been determined to have a free-solution diffu-
sion coefficient of 8.7  107 cm2 s1 (Brown et al., 1999;
Swaminathan et al., 1997). Adjusting for the increased
Stokes’ hydrodynamic radius of the largest construct, PKC-
-GFP, yields a diffusion coefficient on the order of 5 
107 cm2 s1. This value gives a theoretical half-time of
photobleaching recovery of 0.29 s for a bleached area of
radius 8 	m, according to the relationship t1/2 0.224 w2/D
where w is bleach radius (Soumpasis 1983). Even if the
mobility of the applied probes is significantly hindered by
subcellular structures such as the sarcoplasmic reticulum,
mitochondria, and myofilaments, as has been demonstrated
in similar systems (Papadopoulos et al., 2000, and refer-
ences therein), the recovery should still be over seconds or
tens of seconds. Thus, the observed long photobleaching
recovery times, measured in minutes, cannot be due to slow
diffusion of fluorescent probes.
PKC--GFP binding kinetics by wash-in/washout
FRAP measurements provided evidence for reversible
PKC- anchoring with binding and unbinding rates in the
minute time domain. To independently confirm these ob-
servations, we monitored the development or loss of stria-
tions over time after mixing in or washing out PKC--GFP.
Fig. 4 illustrates a representative time course of fluores-
cence changes in a myocyte after rapid introduction of 160
nM PKC--GFP into the chamber. The extracellular (bath)
fluorescence changed from background to a maximum
within one frame (30 s; not shown), but cell-associated
fluorescence increased over several minutes. The striation
pattern developed with a rate constant of 1.5  103 s1
(t1/2  7.7 min) as determined by fitting the data to a
single-exponential function. Assuming the concentration of
PKC--GFP was constant throughout the binding process,
we estimate a second-order rate constant of 1.5  103
s1/1.6  107 M  9  103 M1 s1 for kon. This kon
value is similar to what was measured by FRAP (Table 1).
FIGURE 4 Time course of myocyte fluorescence changes during rapid
mixing. Shown is the original record of fluorescence from a representative
myocyte as activated PKC--GFP (160 nM final concentration) was mixed
into the chamber and then washed out (arrow) with fresh relaxing solution.
The solid lines show fits to single-exponential equations. For the rising
phase, the expression y  yo  a(1  ebx) was used, and the fitted value
for b was kon  9.1  103 s1. For the declining phase, the expression
y  yo  aebx was used, and the fitted value for b was koff  2.0  103
s1. Mean values for kon and koff are compiled in Table 1.
TABLE 1 Summary of kinetic properties of PKC- and V1 binding in cardiac myocytes
Constant
PKC- -V1
FRAP* Perfusion† FRAP* Perfusion† Steady state‡
kon 4.6  1.2  103 M1 s1 9.0  3  103 M1 s1 4.4  1.5  103 M1 s1 12  3  103 M1 s1
koff 0.75  0.1  103 s1 1.4  0.5  103 s1 1.3  0.3  103 s1 3.8  1.1  103 s1
Kd§ 160 nM 150 nM 300 nM 330 nM 290 nM
*Rate constants  SEM derived from linear regression fits of data in Fig. 3 B or 8 B.
†Rate constants derived from exponential fits of data as in Fig. 4. Data represent mean  SEM for a minimum of four measurements from each of five
separate cells.
‡Derived from a least-squares fit to data in Fig. 7 C.
§Calculated as the koff/kon ratio for each column. Errors are estimated to be 30%.
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We next established that PKC- binding near the Z-line
was reversible by rapid addition of fresh relaxing solution
while monitoring fluorescence intensity over time. Fluores-
cence in the bath surrounding the cells declined within one
frame (15 s), showing that the solution change was rapid
(not shown). The fluorescent striation pattern within the cell
declined gradually over the course of hundreds of seconds,
indicating slow unbinding of the probe (Fig. 4). This grad-
ual loss of cell fluorescence was not caused by photobleach-
ing, as it occurred independently of exposure to confocal
laser illumination. The unbinding process followed an ex-
ponential decay of the form y  yo  aebx where b is
equivalent to koff, the unbinding rate constant. The mean koff
compiled from multiple traces was 1.4  0.5  103 s1,
which translates to a half-time for PKC- dissociation of 8.3
min. This rate constant is within a factor of 2 of the koff
value determined by FRAP (Table 1).
Binding of V1-GFP
To investigate which domains of PKC- might be respon-
sible for anchoring to specific cardiac cell structures, we
compared the binding of the N-terminal 144 amino acids,
termed the V1 domain, with that of full-length PKC-. A
typical image of V1-GFP-decorated myocytes is illustrated
in Fig. 5. The striking cross-striated staining pattern evident
in these images is similar to full-length PKC--GFP. How-
ever, unlike the full-length construct, V1-GFP bound con-
stitutively in the absence of any added activators. In addi-
tion, the V1-GFP pattern of fluorescence appears to be
more discretely localized. This we believe is due to the fact
that full-length enzyme exhibits more generalized associa-
tion with intracellular membranes in addition to binding
near the Z-line. Like PKC--GFP, V1-GFP was concen-
trated on the Z-line, as evidenced by co-localization with the
signature Z-line protein -actinin (Fig. 6). In addition, the
binding process for V1-GFP was found to be surprisingly
slow (t1/2 5 min), as observed by mixing of cells with 200
nM V1-GFP and monitoring the development of striations
over time. The V1-GFP probe also bound to myocytes
reversibly, as the cross-striated pattern disappeared shortly
(t1/2  3 min) after perfusing the chamber with relaxing
solution (summarized in Table 1).
The isoform specificity of V1 binding, and by inference
PKC- binding, was tested by use of the analogous 144-
amino-acid N-terminal domain of PKC-, another novel
PKC isozyme present in adult rat cardiac cells. The V1
region of the  isoform of PKC was fused to EGFP and
expressed in DH5 cells and purified as a GST-fusion
product. This construct did not exhibit the sarcomeric bind-
ing properties of V1-GFP but showed only low levels of
diffuse staining (not shown). This observation illustrates the
isoform selectivity of V1 anchoring near the Z-lines in
cardiac cells. It also reinforces the control experiments
performed with EGFP alone. Neither EGFP alone nor V1-
GFP gave rise to a striated sarcomeric pattern of fluores-
cence demonstrating that the pattern observed with V1-
GFP cannot be due to the simple process of filling t-tubules
or other available volume within myocytes with the fluo-
rescent probe.
As with full-length PKC--GFP, the intensity of the stri-
ation pattern observed with V1-GFP varied with the con-
centration of applied probe. In this case due to the avail-
ability of higher concentrations of V1-GFP, it was possible
to demonstrate saturation of binding. Fig. 7 shows a series
of images of cells decorated with increasing concentrations
of V1-GFP. Images such as these were quantitatively an-
alyzed with a series of line-scan plots of pixel intensity
versus position (Fig. 7 B). The heights of the peaks in this
plot indicate the intensity of the striation pattern and are
taken to represent the amount of V1-GFP bound at the
Z-line. Fig. 7 C shows a plot of peak height versus [V1-
GFP] that reveals a saturable binding relationship conform-
ing to a hyperbolic fit of the form y ax/(b x), where b
Kd. From this fit, we determined an apparent Kd of 290 60
nM. The saturation observed was not due to a nonlinear
response of the confocal microscope. Pixel counts of a
rectangular region outside the cells being imaged demon-
strated that the bath fluorescence continued to rise after
saturation of the Z-line had occurred, until [V1-GFP] was
well over 400 nM (Fig. 7 C).
FRAP measurements were also carried out with V1-GFP
(Fig. 8). These measurements were consistent with revers-
ible binding and with slow on and off rates for V1-GFP.
kFRAP was again found to depend upon the concentration of
the GFP construct permitting estimates of kon and koff. The
kon value determined by FRAP was 4.4  1.5  103 M1
s1, quite similar to the kon measured for full-length PKC-
-GFP. The koff value for V1-GFP was 1.3  0.3  103
FIGURE 5 (Left panel) Laser scanning confocal micrograph of an iso-
lated permeabilized myocyte incubated with GFP fused to the V1 region
of PKC-; (Right panel) Autofluorescence of unstained myocytes at the
same confocal microscope settings. Scale bar, 10 	m.
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s1 or about twofold faster than for full-length PKC--GFP.
A detailed comparison of rate constants determined by
wash-in/washout and by FRAP for the two GFP constructs
is given in Table 1. In general, the data are compatible and
present a consistent picture of the dynamics of PKC-
binding to cardiac myocytes. Within a given method of
measurement, on rates were very similar for V1-GFP and
PKC--GFP, and we take this as good evidence that V1 and
PKC--GFP binding have similar kinetic limits. Moreover,
within a given method of measurement, off rates were
consistently faster for V1-GFP (by two- to threefold) than
for PKC--GFP, and we take this as strong evidence that
V1 binds more weakly and dissociates faster than does
full-length PKC-. The sources of systematic errors that
resulted in all FRAP-derived values being approximately
twofold lower than those determined by perfusion may
include photodamage to cells during photobleaching. Over-
all, the data provide a consistent picture of slow binding
kinetics for PKC- that is mimicked by its V1 domain.
Values for Kd derived from rate constants are also pre-
sented in Table 1. Constraining kon to be equivalent for both
constructs, we arrive at a differences in Kd values due to
different koff values of twofold, the full-length enzyme
being more slowly reversible and thus more tightly bound.
Estimates for V1 derived from rate constants are in the
range of 300–330 nM, and a steady state Kd value was
independently measured to be 290 nM. By comparison,
estimates for the Kd of full-length PKC--GFP fall in the
range of 150–160 nM. Thus, these dynamic measurements
not only reveal slow binding and unbinding rates for PKC-
anchoring to structures near the cardiac Z-line but also
reveal a sub-micromolar affinity for this anchoring event.
DISCUSSION
The main findings of the present study are that PKC- binds
in the vicinity of the cardiac Z-lines with binding and
unbinding kinetics in the minute time domain. The observed
on rate for binding measured by FRAP depended upon
PKC--GFP concentration with a slope equal to 
9  103
M1 s1. A similar slow on rate for PKC--GFP binding
was observed in mixing experiments. This value for kon is at
least two orders of magnitude less than a typical diffusion-
controlled reaction rate for a protein of this size (Brown et
al., 1999; Soumpasis, 1983). Thus, it appears that PKC-
binding and by inference its translocation are inherently
slow processes. The effective concentration of PKC- in
vivo is unknown, but if we assume it is approximately equal
to the Kd value estimated here, then this second-order on
rate constant translates to a translocation half-time of 8 min.
This value is similar to translocation time courses that have
been reported previously in intact cells stimulated with
agonists or lipid activators of PKC (Albert and Ford ,1999;
Huang et al., 1997; Yoshida et al., 1996).
It is interesting to note that the binding of exogenous
PKC- applied to permeabilized cells may be slow enough
to account for the rate of onset of PKC-mediated positive
inotropic responses in cardiac myocytes (Huang et al., 1996;
Pi et al., 1997). This suggests that the slow binding kinetics
are an intrinsic property of PKC-, because potential delays
due to receptor activation, coupling to enzyme effectors
such as phospholipase C, and second messenger formation/
diffusion are absent from these measurements. Thus, it is
possible that the cause of the delay between activation of
PKC and its resulting effects may be entirely contained
within the enzyme itself. Such a slow time course, which
implies a large activation energy barrier in the binding of
PKC-, may possibly be due to an unfolding of the protein
structure or other obligatory intramolecular rearrangement.
Perhaps binding of translocation activators induces slow
conformational changes that ultimately expose the binding
surface to its matched anchor and allow accumulation of
PKC- at the Z-line. Mochly-Rosen and colleagues have
suggested an auto-inhibitory mechanism wherein the an-
FIGURE 6 Co-localization of V1 domain with -actinin. (Left panel) Confocal images of permeabilized myocytes decorated with monoclonal
anti--actinin antibody and TRITC-labeled secondary antibodies in the red channel; (Middle panel) V1-GFP fusion construct in the green channel, showing
a striated binding pattern (nuclear staining was not consistently observed); (Right panel) Areas of co-localization of V1-GFP and -actinin appear as yellow
in a red/green overlay.
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chor-binding region of the regulatory domain of PKC- is
obscured until translocation is stimulated (Dorn et al.,
1999). This is analogous to the auto-inhibition of the cata-
lytic domain of PKC by the pseudo-substrate region.
Much about the translocation and anchoring of PKC- is
unknown. Indeed, a critical question that has not been
definitively answered is the identity of the binding partner
that anchors PKC after translocation. Some researchers have
suggested that PKC interacts primarily with the surface of
the phospholipid membrane, whereas others have proposed
protein-binding partners. For example, Cypher-1, a PDZ
domain-containing protein, has been shown to bind both
FIGURE 7 Concentration dependence of V1-GFP binding to permeabilized myocytes. (A) A series of confocal images of permeabilized myocytes
decorated with increasing concentrations of V1-GFP; (B) Line-scan quantification of Z-line fluorescence. The height of the peaks corresponds to striation
intensity, which increases with increasing [V1-GFP]. Interpeak distance represents sarcomere length, 1.7 	m. (C) Quantification of V1-GFP binding to
myocytes based upon peak heights (E, right axis). The regression line represents a least-squares fit to a hyperbolic saturation curve with a Kd of 290 
60 nM. Average pixel intensity of a rectangular reference region outside the cell (F, left axis) demonstrates the linear response of the confocal microscope
at this level of fluorescence. Points marked with an asterisk were considered to be outside of the linear response range and were not included in the
regression analyses. Data represent mean  SD.
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-actinin and several isoforms of PKC including PKC-
(Zhou et al., 1999). Other possibilities include isoform-
specific receptors for activated C kinase (RACKs) (re-
viewed in Mochly-Rosen, 1995) or docking structures such
as caveolae (Rybin et al., 1999). F-actin has also been
implicated in PKC anchoring (Prekeris et al., 1996), al-
though peptide inhibition studies revealed that PKC- an-
choring in Triton-X-100-skinned cardiac cells occurs
through its V1 domain rather than through its recognition
motif for F-actin (Huang and Walker, 1997).
The ratio of the rate constants estimated in this study
gives a dissociation constant for PKC- binding of 
150
nM (Table 1). This is similar to the Kd value of 90 nM
obtained in a centrifugation binding assay using skinned
cardiac myocytes (Huang and Walker, 1997). Previously
there have been few estimates for the apparent affinity of
PKC for its putative anchoring sites. The most thoroughly
investigated anchor for PKC- is RACK2, which is fully
saturated with PKC- in an in vitro assay at 10 nM (Csukai
et al., 1997). A Kd value of 
1 nM is feasible for such an
anchoring protein, if the protein ligand binds with a typical
diffusion-controlled on rate of 106 to 107 M1 s1. How-
ever, such a high affinity is not compatible with the much
slower on rates estimated here. For example, if one assumes
a simple binding mechanism, koff  Kd  kon, then a high
affinity (1 nM) and slow on rate (104 M1 s1) would result
in an unreasonably slow off rate (half-time  19 h). Thus,
the affinity for PKC- in cardiac myocytes in situ may be
significantly lower than what has been measured for
RACK2 in vitro (Csukai et al., 1997). Perhaps other proteins
in the intracellular environment modulate the affinity of
PKC- for RACK2. Alternatively, there may be multiple
classes of anchoring sites with differing affinities and char-
acteristic binding kinetics.
As mentioned above, a slow on rate of 9  103 M1 s1
(t1/2  8 min at 150 nM PKC-) accounts for the time
course of PKC- translocation as well as the onset of PKC-
dependent responses (Huang et al., 1997; Pi et al., 1997).
FIGURE 8 Photobleaching recovery of V1-GFP-decorated myocytes. (A) A permeabilized myocyte equilibrated with 150 nM V1-GFP was photo-
bleached in a 16  16 	m square. Recovery of fluorescence is shown here at 0, 5, 10, and 15 min. (B) A line-scan quantification of fluorescence intensity
versus position across the bleached region shows a uniform recovery of fluorescence over time. (C) Rate of photobleaching recovery, kFRAP, depends upon
the concentration of applied probe. Linear regression analysis gives a slope, kon  4.4  1.5  103 M1 s1, and a y-intercept, koff  1.3  0.3  104
s1. Overlapping data are offset. (Inset) Mean kFRAP values SEM at low (75 nM) and high (300 nM) concentrations of PKC--GFP. Data are represented
as mean  SEM; asterisk indicates statistical significance with p 	 0.05.
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The experimentally determined off rate of 1  103 s1
(t1/2  11 min) is also consistent with the time course of
recovery from PKC-dependent responses (He et al., 2000;
Pi et al., 1997). In addition, the observed on and off rates are
compatible with the time course of ischemic precondition-
ing, which typically takes 5–15 min to develop and lasts
30–90 min (Lawson and Downey, 1993). Thus, it is possi-
ble that the window of protection provided by ischemic
preconditioning is defined in part by the inherently slow
binding and unbinding of activated PKC-.
Previously, several domains of PKC have been suggested
to be important for translocation and anchoring in vivo. The
C1 region is known to mediate an avid membrane interac-
tion when bound to diacylglycerol or phorbol esters. These
PKC activators significantly increase the enzyme’s mem-
brane affinity, probably by contributing to a hydrophobic
surface of C1 (Zhang et al., 1995). This role for C1 is
supported by our data, because the full-length PKC--GFP
construct, which contains the C1-domain, seems to bind
more effectively to membrane structures than does V1-
GFP, producing a staining pattern typical of a membrane-
binding probe characterized by longitudinal streaks and
perinuclear staining. We have consistently observed intense
PKC--GFP decoration of the conical, membrane-rich re-
gions flanking the nucleus. It is unclear whether this is a
generalized membrane-binding phenomenon or a specific
receptor-mediated interaction of the sort shown for PKC-
binding to Golgi in vitro (Csukai et al., 1997).
In a comprehensive study of the kinetics of translocation
of PKC- in cultured RBL cells, Oancea and Meyer (1998)
demonstrated a rapid Ca2-dependent interaction between
its C2 domain and the cell membrane. Interestingly, PKC-
could also be induced to undergo membrane association in
the absence of Ca2 if phorbol ester was the activating
ligand. The time course of PKC- translocation was greatly
slowed (t1/2  4 min) under these conditions making the
time frame similar to PKC- translocation described here in
cardiac cells. Oancea and Meyer (1998) proposed that the
slow kinetics were due to conformational changes in the
regulatory domain that unmask the C1 phorbol ester binding
site making it available for a productive membrane interac-
tion. In light of our observations with V1-GFP, we propose
that the critical rate-determining conformational changes
reside in the V1 domain itself for PKC-. One may speculate
that the in vivo anchoring of PKC is mediated by both V1
and C1 elements, acting simultaneously or sequentially to
achieve specific receptor interactions as well as generalized
membrane binding. Analogous cooperative binding interac-
tions have been described for the C1 and C2 domains of
conventional PKC isoforms (Medkova and Cho, 1999).
Other important issues include identifying the substrates
that PKC- phosphorylates as a result of translocation and
anchoring and establishing precisely how phosphorylation
is transduced into the various PKC-mediated effects that
have been widely observed. The fact that the -isoform of
PKC ultimately binds at the Z-line is suggestive of a mech-
anism by which PKC might exert its effects in the heart. The
Z-line and its adjacent structures have long been known to
be involved in excitation-contraction (EC) coupling, and it
seems clear that a kinase anchored on or near the Z-line
would be strategically positioned to modulate several key
players. First among these are the L-type calcium channels,
which are located on the transverse tubules that penetrate
the sarcolemma near the Z-line. These channels are closely
aligned with ryanodine receptors (RyRs) at close apposi-
tions between the transverse tubule and sarcoplasmic retic-
ulum, called dyad junctions. Together, the L-type channels
and the RyR coordinate the release of calcium in response to
sarcolemma depolarization and are the subjects of a variety
of cardiac regulatory cascades. The L-type calcium channel,
in particular, is a likely substrate for PKC- and has been
shown to respond to photorelease of a caged form of the
PKC activator dioctanoylglycerol with an increase in peak
current (He et al., 2000). This increase in ICa is concentra-
tion dependent and blockable with the PKC inhibitor chel-
erythrine. Consequently, our observations of PKC- binding
at the Z-line have implications for its role in contractility
modulation via regulation of EC coupling.
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